TigerGene is a venture capital firm established in 2018 and located in Cambridge, Massachusetts. The company focuses on investing in platform technology firms, particularly those within the life sciences sector, that have the potential to develop disruptive technologies and high-growth trajectories. By identifying and supporting innovative companies with strong intellectual property portfolios, TigerGene aims to foster advancements in technology that can significantly impact various industries.
Valora Therapeutics, based in San Diego, California, is a biotechnology company focused on the development of innovative biological drugs. It specializes in engineering chimeric antibodies, which are designed to harness the body's immune system to fight cancer and other diseases. The company operates at the pre-clinical stage, working to unlock new mechanisms of immune signaling and activity, with the aim of providing transformative therapies to the healthcare industry.
NanoMosaic
Series A in 2021
NanoMosaic specializes in developing innovative solutions for early illness detection, prognostic monitoring, and biomarker identification. The company utilizes a unique nanoneedle proteomic platform that facilitates protein detection and quantification on a single chip. This technology enhances the capabilities of the medical and healthcare industry by accelerating the discovery and validation of biomarkers, thereby improving early disease detection and monitoring. Through its advanced proteomic system, NanoMosaic aims to contribute significantly to advancements in medical diagnostics and patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.